Studies
Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer, including KRAS and Her2
Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer, including KRAS and Her2
Request Access
Overview
Selected Publications (1)
Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations
Joshua R. Veatch, Brenda Jesernig, Julia Kargl, et al.. (2019). Cancer Immunology Research. Cited 80 times.
https://doi.org/10.1158/2326-6066.CIR-18-0402
